REMODEL - Renal mode of action of semaglutide in patients with type 2 diabetes and chronic kidney disease
Details
Age
Adult
Locations
Barbara Davis Center
Childrens Hospital Colorado
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Jessica Kendrick
Study ID
Protocol Number: 21-2645
More information available at ClinicalTrials.gov: NCT04865770
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers